200937-21-9

Basic information

• Product Name: Boc-DL-Leu-OH H2o
• Synonyms: N-[(1,1-Dinethylethoxy)carbonyl]-leucine Monohydrate;N-[(1,1-Dimethylethoxy)carbonyl]leucine monohydrate;(RS)-Boc-2-amino-4-methyl-pentanoic acid hydrate;Boc-DL-leucine hydrate99%;(Tert-Butoxy)Carbonyl DL-Leu-OH·H2O
• CAS NO: 200937-21-9
• Molecular Formula: C11H23NO5
• Molecular Weight: 249.30402
• Mol File: 200937-21-9.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: Store at RT.
• CAS DataBase Reference: Boc-DL-Leu-OH H2o(CAS DataBase Reference)
• NIST Chemistry Reference: Boc-DL-Leu-OH H2o(200937-21-9)
• EPA Substance Registry System: Boc-DL-Leu-OH H2o(200937-21-9)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 200937-21-9(Hazardous Substances Data)

Usage

General Description

Boc-DL-Leu-OH H2o is a chemical compound with the molecular formula C14H27NO5. It is a derivative of the amino acid leucine, with an added Boc (tert-butoxycarbonyl) protecting group. Boc-DL-Leu-OH H2o is often used in peptide synthesis as a building block for creating larger peptides and proteins. The Boc protecting group helps to prevent unwanted reactions at the amino group, allowing for selective modification at other sites on the molecule. Boc-DL-Leu-OH H2o is commonly used in research and pharmaceutical industries for the production of peptide-based drugs and compounds.

Downstream Products

• 84863-67-2 (S)-t-butyl 1-(isopentylamino)-4-methyl-1-oxopentan-2-ylcarbamate 
• 87694-50-6 N-(tert-butoxycarbonyl)-L-leucine-N'-methoxy-N'-methylamide 
• 1349748-73-7 (S)-2-(3-benzylureido)-N-(cyanomethyl)-4-methylpentanamide 
• 58521-45-2 tert-butoxycarbonyl-L-leucinal 
• 129603-18-5 (R)-2-methyl-4-aminononane hydrochloride 
• 129603-19-6 (S)-2-methyl-4-aminononane hydrochloride 
• 129603-01-6 (R)-N^α-(tert-butoxycarbonyl)-N-methoxy-N-methylleucinamide 
• 248922-19-2 (S)-2-[Bis-(4-tert-butoxy-benzyl)-amino]-1-{4-[bis-(4-fluoro-phenyl)-methyl]-piperazin-1-yl}4-methyl-pentan-1-one 
• 248922-21-6 (S)-2-[Bis-(4-tert-butyl-benzyl)-amino]-1-{4-[bis-(4-fluoro-phenyl)-methyl]-piperazin-1-yl}-4-methyl-pentan-1-one 
• 248922-23-8 (S)-1-{4-[Bis-(4-fluoro-phenyl)-methyl]-piperazin-1-yl}-4-methyl-2-(3,4,5-trimethoxy-benzylamino)-pentan-1-one 
• 248922-27-2 (S)-1-{4-[Bis-(4-fluoro-phenyl)-methyl]-piperazin-1-yl}-2-(4-tert-butoxy-benzylamino)-4-methyl-pentan-1-one 
• 248922-20-5 (S)-1-{4-[Bis-(4-fluoro-phenyl)-methyl]-piperazin-1-yl}-2-(4-tert-butyl-benzylamino)-4-methyl-pentan-1-one 
• 248922-25-0 (S)-2-Benzylamino-1-{4-[bis-(4-fluoro-phenyl)-methyl]-piperazin-1-yl}-4-methyl-pentan-1-one 
• 248921-97-3 (S)-(1-{4-[Bis-(4-fluoro-phenyl)-methyl]-piperazin-1-ylmethyl}-3-methyl-butyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

Tumor metastasis inhibiting compounds and methods

A peptide derivative containing 1 to 20 units of peptide unit represented by the following general formula [I] or a pharmaceutically acceptable salt thereof; wherein Arg represents L- or D-arginine residue, Asp represents L-aspartic acid residue, X represents L- or D-leucine, D-isoleucine, L- or D-norleucine, L- or D-phenylalanine, D-phenylglycine or D-alanine residue, and [Z] and [Y] each represents an amino acid or a peptide residue, which may be present or absent, selected from glycine, L-serine, L-threonine, L- and D-aspartic acid, L-alanine, L- and D-glutamic acid, L-proline residues and a peptide residue constituted by the foregoing amino acid residues, and a pharmaceutical composition comprising the peptide derivative. The composition of the present invention is useful as an agent for inhibiting tumor metastasis.